AG
ADMA icon

Algert Global’s ADMA Biologics ADMA Stock Holding History

Algert Global’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.51M Buy
777,189
+421,247
+118% +$3.84M 0.08% 429
2026
Q1 		$3.21M Buy
355,942
+118,970
+50% +$1.88M 0.05% 575
2025
Q4 		$4.32M Buy
236,972
+183,873
+346% +$3.1M 0.07% 493
2025
Q3 		$778K Sell
53,099
-221,880
-81% -$3.8M 0.01% 873
2025
Q2 		$5.01M Buy
274,979
+89,140
+48% +$1.82M 0.1% 329
2025
Q1 		$3.69M Sell
185,839
-86,510
-32% -$1.5M 0.09% 383
2024
Q4 		$4.67M Buy
272,349
+67,961
+33% +$1.28M 0.11% 305
2024
Q3 		$4.09M Buy
204,388
+86,098
+73% +$1.34M 0.11% 323
2024
Q2 		$1.32M Buy
118,290
+105,593
+832% +$886K 0.04% 601
2024
Q1 		$83.8K Buy
+12,697
New +$69.4K ﹤0.01% 1020
2023
Q4 		– Sell
-22,420
Closed -$80.3K – 1114
2023
Q3 		$80.3K Buy
+22,420
New +$86.3K ﹤0.01% 1045
2020
Q1 		– Sell
-17,400
Closed -$70K – 405
2019
Q4 		$70K Buy
+17,400
New +$75.8K 0.02% 358

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Algert Global's ADMA Position: Q2 2026 in Review

Algert Global increased its ADMA Biologics (ADMA) stake by 118% in Q2 2026, buying an estimated $3.84M and bringing the position to 777,189 shares worth $6.51M. The position accounts for 0.08% of the portfolio, ranked #429.

Algert Global first reported a position in ADMA in Q4 2019 and has held it in 12 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Algert Global held 777,189 shares of ADMA Biologics worth $6.51M as of Q2 2026.
  • Algert Global bought 421,247 ADMA Biologics shares in Q2 2026, an estimated $3.84M.
  • ADMA Biologics made up 0.08% of Algert Global's portfolio in Q2 2026, its #429 holding.
  • Algert Global first reported a position in ADMA Biologics in Q4 2019 and has held it in 12 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.